Anlon Healthcare posts strong Q2 growth, but operating cash flow turns negative

Revenue Growth 20pctPat Growth 25pctNegative Operating CashflowResults View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.9%Reaction day

₹25.22

prior close

₹26.36

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is usedpendingvs market: pending

Pharmaceuticals peers, median of 173sector-0.8%+3.7% vs sector

On the reaction day the stock moved 3.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.0

15m

+0.0

30m

-3.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.9pendingpending-0.8+3.7

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited results for the quarter and half year ended September 30, 2026. Consolidated quarterly revenue rose 102% to Rs 10,560.97 lakh, while profit after tax rose 84% to Rs 1,717.80 lakh. Half-year revenue was Rs 19,317.24 lakh and profit Rs 2,545.94 lakh. Operating cash flow was negative Rs 794.25 lakh. The auditor found no material misstatement.

Likely market impact

Strong sales and profit growth supports sentiment, but negative operating cash flow and rising inventories and receivables may weigh on near-term performance.